Showing results (291-300 of 599) with videos related to

Sort By:
Pageof 60
Cancer Cell|June 15, 2016
miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic LeukemiaSilvia Nucera, Alice Giustacchini, Francesco Boccalatte, et al.
British Journal of Haematology|March 17, 2026
Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in ItalyElena Sabattini, Stefano Ascani, Sabino Ciavarella, et al.
Histopathology|June 22, 2012
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomasBrunangelo Falini, Claudio Agostinelli, Barbara Bigerna, et al.
Haematologica|March 20, 2025
Dissecting CD47 expression in lymphoid neoplasms to inform precision immunotherapy with anti-CD47 phagocytic checkpoint blockadeAndrea Marra, Alan Ramsay, Samuel Chamberlain-Keene, et al.
Blood|March 16, 2002
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trialFrancesco Bertoni, Annarita Conconi, Carlo Capella, et al.
Cancers|January 21, 2023
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 StudyJennifer A Woyach, Paul M Barr, Thomas J Kipps, et al.
Hemasphere|July 8, 2025
A spheroid model that recapitulates the protective role of the lymph node microenvironment and serves as a platform for drug testing in chronic lymphocytic leukemiaElisa Lenti, Edoardo Visentin, Engin Bojnik, et al.
Hemasphere|July 22, 2024
Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunitiesKostas Stamatopoulos, Sarka Pavlova, Othman Al-Sawaf, et al.
Frontiers in Immunology|February 20, 2018
First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the LiteratureMaddalena Migliavacca, Andrea Assanelli, Maurilio Ponzoni, et al.
Blood|March 1, 2007
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantationFabio Ciceri, Chiara Bonini, Sarah Marktel, et al.
Pageof 60